RxDoctor Payments Data

Roger Pearse, MD

Medical Oncology · New York, NYNPI 1518057785

Payments from drug & device makers

$574,168in general payments, 2019–2025

Across 45 payments — averaging $12,759 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$410K
  • Bristol Myers Squibb$103K
  • Amgen$58K
  • E.r. Squibb & Sons, L.L.C.$2K
  • ZOLL Medical Corporation$325
  • Regeneron$128
  • plus $225 from 3 others

What the payments were for

  • Consulting fees$42559%
  • Food & beverage$29741%

General payments by program year

19
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$574,168 in reported general payments places this provider in the 60th percentile of 498 medical oncology providers in New York.

See all medical oncology providers in New York

Medicare billing

Part B allowed, 2024
$3,516,250
Medicare patients
234
Services billed
80,052

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ValacyclovirValacyclovir Hcl14$641

Paid to pharmacies, not to this prescriber.

Other medical oncology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →